Transparency and reproducibility in data analysis: The Prostate Cancer Prevention Trial

Biostatistics

Volumn 11, Issue 3, 2010, Pages 413-418

  Baker, Stuart G ^a   Darke, Amy K ^b   Pinsky, Paul ^a   Parnes, Howard L ^a   Kramer, Barnett S ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Categorical data; Maximum likelihood; Missing data; Multinomial Poisson transformation; Propensityto be missing score; Randomized trials

Indexed keywords

ENZYME INHIBITOR; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BIOPSY; BLOOD; CLINICAL TRIAL; DIGITAL RECTAL EXAMINATION; HUMAN; MALE; PROSTATE TUMOR; REPRODUCIBILITY; STANDARD; STATISTICAL ANALYSIS;

BIOPSY; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; DIGITAL RECTAL EXAMINATION; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 77956632782     PISSN: 14654644     EISSN: 14684357     Source Type: Journal    
DOI: 10.1093/biostatistics/kxq004     Document Type: Article

References (7)

1. BAKER, S. G. (1994). The multinomial-Poisson transformation. The Statistician 43, 495-504.
2. BAKER, S. G., FITZMAURICE, G., FREEDMAN, L. S. AND KRAMER, B. S. (2006). Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates. Biostatistics 7, 29-40.
3. PINSKY, P., PARNES, H. AND FORD, L. (2008). Estimating rates of true high-grade disease in the Prostate Cancer Prevention Trial. Cancer Prevention Research 1, 182-186.
4. PENG, R. D. (2009). Reproducible research and Biostatistics. Biostatistics 10, 405-408.
5. REDMAN, M. W., TANGEN, C. M., GOODMAN, P. J., LUCIA, S., COLTMAN, JR, C. A. AND THOMPSON, I. M. (2008). Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach. Cancer Prevention Research 1, 174-181.
6. SHEPHERD, B. E., REDMAN, M. W. AND ANKERST, D. P. (2008). Does fnasteride affect the severity of prostate cancer? A causal sensitivity analysis. Journal of the American Statistical Association 103, 1392-1404.
7. THOMPSON, I. M., GOODMAN, P. J., TANGEN, C. M., LUCIA, M. S. MILLER, G. J., FORD, L. G., LIEBER, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M. and others (2003). The infuence of fnasteride on the development of prostate cancer. The New England Journal of Medicine 349, 215-224.